Key result
Sustained epicardial delivery of bFGF and VEGF from alginate beads reduced the distribution volume for GdDTPA (0.44 vs 0.68, p=0.02) and facilitated vascular growth in cryoinjured pig hearts.
Why the study?
Does intrapericardial delivery of bFGF and VEGF embedded in alginate beads improve perfusion and reduce injury size in a pig model of myocardial cryoinjury?
Does intrapericardial delivery of bFGF and VEGF embedded in alginate beads improve perfusion and reduce injury size in a pig model of myocardial cryoinjury?
Absolute Event Rate: 0.44% vs 0.68%
p-value: p=0.02
Sustained intrapericardial release of bFGF and VEGF from alginate beads attached to the epicardium facilitated vascular growth and improved perfusion in a pig model of myocardial cryoinjury.
May inform epicardial delivery strategies in animal models; leaves open clinical translation for perfusion or injury size.
The aim of the study was the testing of sustained intrapericardial delivery of vascular growth factors (GFs) from alginate beads on cryoinjury size and perfusion. In domestic pigs (15-20 kg, n = 21), the left ventricular (LV) anterolateral wall of exposed hearts was cryoinjured using an aluminum rod (25 mm o.d.) cooled in liquid nitrogen. Alginate beads (d = 3.2 ± 0.2 mm), containing human recombinant basic fibroblast GF (bFGF, 50 µg) and vascular endothelial GF (VEGF, 50 µg) + heparin (50 µg) or heparin alone (Con, n = 5), were sutured to the cryoinjured epicardium (GF, n = 5; Con, n = 3 ) or pericardium (GF, n = 3; Con, n = 2), or no beads were implanted (n = 4). Four pigs were sham-operated. Cine and T(1) -weighted MRI was performed in vivo at ~2.5 h and 1, 2, 3 and 4 weeks after injury in a 3T imager. A double bolus of GdDTPA was injected (0.05 and 0.15 mmol/kg) and first-pass and late enhancement kinetics were monitored. After 4-week cryoinjury, following the injection of 5 x 10(6) 15-µm NIR fluorescent microspheres (FMS, 645/680 nm), hearts were sliced and examined with fluorescence imaging. Triphenyltetrazolium chloride (TTC) staining was used to determine infarct areas. Epicardial GF-containing beads were encapsulated within the hypointense 3-4-week infarct tissue. This tissue had a 75% higher LV thickening index, a lower distribution volume for GdDTPA (0.44 ± 0.12 vs 0.68 ± 0.05, p = 0.02), and 25% faster first-pass Gd kinetics relative to control infarctions. TTC staining revealed TTC-positive islands in the core of treated infarcts, which showed higher FMS fluorescence relative to surrounding infarct tissue (0.64 ± 0.14 vs. 0.31 ± 0.14; p < 0.0001) and to control infarcts (0.37 ± 0.09, p < 0.05). GF-beads attached to the pericardium were not effective. We conclude that sustained intrapericardial release of bFGF + VEGF from alginate beads attached to the epicardium facilitated vascular growth in the cryoinjured area.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2011) studied Cryoinjury infarction (n=21). bFGF and VEGF embedded in alginate beads vs. Heparin alone or no beads was evaluated on Distribution volume for GdDTPA (p=0.02). Sustained epicardial delivery of bFGF and VEGF from alginate beads reduced the distribution volume for GdDTPA (0.44 vs 0.68, p=0.02) and facilitated vascular growth in cryoinjured pig hearts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: